Prudential Financial Inc Abb Vie Inc. Transaction History

Prudential Financial Inc

$80 Billion
Q3 2025

A detailed history of Prudential Financial Inc transactions in Abb Vie Inc. stock. As of the latest transaction made, Prudential Financial Inc holds 1,858,171 shares of ABBV stock, worth $435 Million. This represents 0.54% of its overall portfolio holdings.

Number of Shares

1,858,171

Previous 1,915,494 2.99%

Holding current value

$435 Million

Previous $356 Million 21.01%

% of portfolio

0.54%

Previous 0.48%

44 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 13, 2025	SELL	$184.85 - $231.54 $10.6 Million - $13.3 Million	-57,323 Reduced 2.99%	1,858,171 $430 Million
Q2 2025 Aug 12, 2025	BUY	$170.16 - $206.27 $35.9 Million - $43.5 Million	211,080 Added 12.38%	1,915,494 $356 Million
Q1 2025 May 13, 2025	SELL	$169.2 - $216.66 $5.11 Million - $6.54 Million	-30,181 Reduced 1.74%	1,704,414 $357 Million
Q4 2024 Feb 11, 2025	SELL	$164.99 - $203.87 $61.3 Million - $75.8 Million	-371,567 Reduced 17.64%	1,734,595 $308 Million
Q3 2024 Nov 13, 2024	SELL	$163.84 - $199.33 $27.4 Million - $33.3 Million	-166,963 Reduced 7.35%	2,106,162 $416 Million

Q2 2024 Aug 13, 2024	SELL	$154.79 - $180.76 $42.2 Million - $49.3 Million	-272,515 Reduced 10.71%	2,273,125 $390 Million
Q1 2024 May 14, 2024	SELL	$159.82 - $182.1 $64.2 Million - $73.2 Million	-401,829 Reduced 13.63%	2,545,640 $464 Million
Q4 2023 Feb 13, 2024	SELL	$137.6 - $154.97 $5.24 Million - $5.9 Million	-38,070 Reduced 1.28%	2,947,469 $457 Million
Q3 2023 Nov 13, 2023	BUY	$133.59 - $154.65 $38.4 Million - $44.5 Million	287,604 Added 10.66%	2,985,539 $445 Million
Q2 2023 Aug 11, 2023	BUY	$132.51 - $164.9 $33.2 Million - $41.3 Million	250,265 Added 10.22%	2,697,935 $363 Million
Q1 2023 May 12, 2023	BUY	$144.61 - $166.54 $4.47 Million - $5.15 Million	30,894 Added 1.28%	2,447,670 $390 Million
Q4 2022 Feb 14, 2023	SELL	$138.31 - $165.87 $7.73 Million - $9.27 Million	-55,872 Reduced 2.26%	2,416,776 $0
Q3 2022 Nov 04, 2022	SELL	$134.21 - $153.93 $29 Million - $33.2 Million	-215,845 Reduced 8.03%	2,472,648 $332 Million
Q2 2022 Aug 15, 2022	SELL	$137.62 - $174.96 $20.2 Million - $25.6 Million	-146,499 Reduced 5.17%	2,688,493 $412 Million
Q1 2022 May 13, 2022	SELL	$131.98 - $163.75 $33.5 Million - $41.6 Million	-253,778 Reduced 8.22%	2,834,992 $460 Million
Q4 2021 Feb 14, 2022	SELL	$107.43 - $135.93 $20.2 Million - $25.5 Million	-187,748 Reduced 5.73%	3,088,770 $418 Million
Q3 2021 Nov 15, 2021	BUY	$106.4 - $120.78 $20.2 Million - $23 Million	190,175 Added 6.16%	3,276,518 $353 Million
Q2 2021 Aug 16, 2021	SELL	$105.21 - $117.21 $32 Million - $35.7 Million	-304,414 Reduced 8.98%	3,086,343 $348 Million
Q1 2021 May 12, 2021	BUY	$102.3 - $112.62 $21 Million - $23.1 Million	205,368 Added 6.45%	3,390,757 $367 Million
Q4 2020 Feb 16, 2021	BUY	$80.49 - $108.67 $254 Million - $344 Million	3,161,315 Added 13131.66%	3,185,389 $341 Million
Q3 2020 Aug 05, 2021	SELL	$85.91 - $100.83 $270 Million - $317 Million	-3,143,847 Reduced 99.24%	24,074 $2.11 Million
Q3 2020 Nov 16, 2020	BUY	$85.91 - $100.83 $271 Million - $318 Million	3,151,730 Added 19465.94%	3,167,921 $277 Million
Q2 2020 Aug 05, 2021	SELL	$73.37 - $98.18 $238 Million - $319 Million	-3,244,919 Reduced 99.5%	16,191 $1.59 Million
Q2 2020 Aug 12, 2020	BUY	$73.37 - $98.18 $238 Million - $319 Million	3,249,134 Added 27130.38%	3,261,110 $320 Million
Q1 2020 Aug 05, 2021	SELL	$64.5 - $97.79 $215 Million - $325 Million	-3,326,920 Reduced 99.64%	11,976 $912,000
Q1 2020 May 12, 2020	BUY	$64.5 - $97.79 $215 Million - $326 Million	3,329,812 Added 36655.79%	3,338,896 $254 Million
Q4 2019 Aug 05, 2021	SELL	$72.13 - $90.25 $208 Million - $261 Million	-2,889,444 Reduced 99.69%	9,084 $804,000
Q4 2019 Feb 11, 2020	BUY	$72.13 - $90.25 $209 Million - $261 Million	2,891,992 Added 44247.12%	2,898,528 $257 Million
Q3 2019 Aug 05, 2021	SELL	$62.98 - $75.72 $184 Million - $221 Million	-2,917,046 Reduced 99.78%	6,536 $495,000
Q3 2019 Nov 13, 2019	BUY	$62.98 - $75.72 $184 Million - $221 Million	2,916,895 Added 43620.38%	2,923,582 $221 Million
Q2 2019 Aug 05, 2021	SELL	$65.7 - $83.98 $187 Million - $239 Million	-2,844,882 Reduced 99.77%	6,687 $486,000
Q2 2019 Aug 08, 2019	BUY	$65.7 - $83.98 $187 Million - $239 Million	2,846,362 Added 54664.14%	2,851,569 $0
Q1 2019 Aug 05, 2021	SELL	$77.14 - $90.79 $139 Million - $164 Million	-1,808,018 Reduced 99.71%	5,207 $420,000
Q1 2019 May 15, 2019	BUY	$77.14 - $90.79 $140 Million - $164 Million	1,810,551 Added 67709.46%	1,813,225 $0
Q4 2018 Aug 05, 2021	SELL	$77.85 - $96.01 $169 Million - $209 Million	-2,172,921 Reduced 99.88%	2,674 $247,000
Q4 2018 Feb 07, 2019	BUY	$77.85 - $96.01 $169 Million - $209 Million	2,174,736 Added 253170.66%	2,175,595 $201 Million
Q3 2018 Sep 01, 2021	SELL	$88.91 - $98.84 $180 Million - $200 Million	-2,022,567 Reduced 99.96%	859 $81,000
Q3 2018 Nov 07, 2018	BUY	$88.91 - $98.84 $180 Million - $200 Million	2,023,279 Added 1376380.25%	2,023,426 $0
Q2 2018 Sep 01, 2021	SELL	$89.78 - $106.23 $257 Million - $304 Million	-2,863,247 Reduced 99.99%	147 $14,000
Q2 2018 Aug 13, 2018	BUY	$89.78 - $106.23 $257 Million - $304 Million	2,863,308 Added 3329428.0%	2,863,394 $0
Q1 2018 Sep 01, 2021	SELL	$92.01 - $123.21 $416 Million - $557 Million	-4,516,893 Reduced 100.0%	86 $8,000
Q1 2018 May 04, 2018	SELL	$92.01 - $123.21 $79.6 Million - $107 Million	-865,368 Reduced 16.08%	4,516,979 $0
Q4 2017 Feb 13, 2018	BUY	$89.56 - $98.21 $1.95 Million - $2.14 Million	21,816 Added 0.41%	5,382,347 $521 Million
Q3 2017 Nov 02, 2017	BUY	$69.85 - $89.22 $374 Million - $478 Million	5,360,531	5,360,531 $476 Million

Others Institutions Holding ABBV

# of Institutions

4,489

Shares Held

1.28B

Call Options Held

16.9M

Put Options Held

15.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $414B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Prudential Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Prudential Financial Inc with notifications on news.

Account

Prudential Financial Inc Abb Vie Inc. Transaction History